CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Reconciliation of net income (loss) to cash used by operating activities:
Net income (loss)	$ 6,210	$ (5,218)
Add (deduct):
Depreciation and amortization	15,384	14,906
Adjustments for bad debt provisions	818	590
Net realized and unrealized (gains) losses	(7,038)	1,778
Amortization of net (discount) premium on debt securities investments	(9)	230
Payments for title losses in excess of provisions	(5,432)	(15,797)
Adjustments for insurance recoveries of title losses	208	0
Increase in receivables – net	(12,674)	(13,724)
Increase in other assets – net	(5,582)	(4,506)
Decrease in accounts payable and other liabilities – net	(24,444)	(34,656)
Change in net deferred income taxes	(5)	1,724
Net loss (income) from equity method investments	10	(28)
Dividends received from equity method investments	229	680
Stock-based compensation expense	2,670	2,759
Other – net	67	200
Cash used by operating activities	(29,588)	(51,062)
Investing activities:
Proceeds from sales of investments in securities	20,874	26,772
Proceeds from matured investments in debt securities	6,646	25,338
Purchases of investments in securities	(23,677)	(23,965)
Net purchases of short-term investments	(4,927)	(2,541)
Purchases of property and equipment and other long-lived assets	(10,218)	(8,894)
Proceeds from sale of property and equipment and other assets	8	49
Cash paid for acquisition of businesses	0	(21,500)
Increase in notes receivable	(6,320)	(168)
Purchases of cost-basis and other investments	(29,939)	(89)
Other – net	176	186
Cash used by investing activities	(47,377)	(4,812)
Financing activities:
Proceeds from notes payable	3,387	3,521
Payments on notes payable	(3,378)	(5,589)
Distributions to noncontrolling interests	(3,720)	(3,775)
Repurchases of Common Stock	(3,390)	(1,271)
Proceeds from stock option and employee stock purchase plan exercises	3,583	1,991
Cash dividends paid	(13,067)	(12,260)
Payment of contingent consideration related to acquisitions	(186)	0
Cash used by financing activities	(16,771)	(17,383)
Effects of changes in foreign currency exchange rates	(1,278)	(295)
Change in cash and cash equivalents	(95,014)	(73,552)
Cash and cash equivalents at beginning of period	233,365	248,367
Cash and cash equivalents at end of period	$ 138,351	$ 174,815